ClinicalTrials.gg
CompletedNCT06925087DysmenorrheaUpdated Apr 13, 2025

Comparison of Acute Effects of Myofascial Release and Kinesio Taping® in Dysmenorrhea

An interventional study of Myofascial Release Technique and Kinesio Taping Technique in Kinesio Taping, Myofascial Release Technique and Pain, sponsored by Cyprus International University. Completed at 2 sites in Turkey. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-13.

Sponsored by Cyprus International University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 3 years 2 months after the study started (first participant enrolled Feb 2022, registered Apr 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,722 studies in Pain with a site in Turkey — 321 open to participants now, 374 under way, none of them phase 3. Pain · Turkey.

Enrollment
1,169th of 1,499
45 · median 70
Started
2022
with 211 others
No phase
1,457 of 1,722
259 open now
Registered
1,186th of 1,722
by date

Among the 1,722 studies in Pain with a site in Turkey, this one is the 1,169th largest by enrollment of the 1,499 interventional ones that give a count, is one of 212 that started in 2022, is one of 1,457 with no phase, and was the 1,186th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

321 of the 1,722 studies in Pain with a site in Turkey are open now. Recruiting first, the newest first:

316 more — sign in →

All 321 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 45 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,722 studies in Pain with a site in Turkey, or all of them as a file.
02

Study summary

Dysmenorrhea is a physiological condition and one of the most common issues experienced during menstruation. This study aims to compare the acute effects of Myofascial Release Technique (MRT) and Kinesio Taping® (KT) on pain severity, fatigue, and menstrual symptom severity in individuals with primary dysmenorrhea (PD).

Read the detailed description

A total of 45 individuals diagnosed with PD will be randomly assigned to one of three groups: MRT, KT, or control. Pain severity and fatigue will be measured using the Visual Analog Scale (VAS), while menstrual symptom severity will be assessed with the Menstrual Symptom Scale, both prior to and following the interventions. The MRT group will be received MRT for three consecutive days starting from the onset of menstruation, whereas the KT group will be applied KT application for a duration of 72 hours. The control group did not receive any form of intervention.

03

Conditions studied

  • Kinesio Taping
  • Myofascial Release Technique
  • Pain
  • Primary Dysmenorrhea (PD)

Browse trials for

Keywords

  • Kinesio Taping
  • Menstruation
  • Primary dysmenorrhea
  • Myofascial release technique
  • Physiotherapy
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Daignosed with primary dysmenorrhea
  • Regular menstruation in the past six months
  • Experience menstrual pain ranging between 40-100 mm on the Visual Analog Scale

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of secondary dysmenorrhea
  • A menstrual cycle length of less than 21 days or more than 35 days
  • A history of childbirth or pregnancy
  • Use of pharmacological treatments for menstrual pain
  • A history of pelvic pathology or pelvic surgery
  • The presence of neurological or systemic diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
45 participants (actual)

Study arms

  • Active comparator
    Myofascial Release Technique Group

    During the application of Myofascial Release Technique (MRT), the fingers or hand will be first placed on the treatment area. Pressure will be applied to the soft tissue until the restricted layer was felt, and then the fascia was moved along the surface of the underlying layers while maintaining contact with the deeper layers. Tension will be applied for approximately 60-90 seconds, and if a release will not felt, the duration will extended until the release occurred. MRT will be performed with dry hands, without the use of any intermediary substances, and will be applied in both supine and prone positions. In the treatment program, anterolateral release techniques (targeting fascia superficialis, fascia transversalis, and fascia extraperitonealis) will be applied in the supine position, while posterior release techniques (targeting fascia thoracolumbalis and erector spinae) will be applied in the prone position.

    Other: Myofascial Release Technique

  • Active comparator
    Kinesio Taping Group

    Two different techniques will be used in the Kinesio Taping application. First, four I-shaped Kinesio tapes (Kinesio Tex® Gold), each 5 cm wide and 0.5 mm thick, will be applied in a star-shaped pattern using the "space correction technique" with 25-50% tension at the S2-S4 level (sacral region) while the participant will in a seated position. Additionally, to direct the uterus into retroversion during menstruation, a 15 cm long I-shaped tape will be applied to the suprapubic region using the "ligament correction technique" with 100% tension.

    Other: Kinesio Taping Technique

  • No intervention
    Control Group

    No intervention will be applied to the control group. After the study will be completed, participants in the control group will be offered their preferred treatment option.

Interventions

  • OtherMyofascial Release Technique

    During the application of Myofascial Release Technique (MRT), the fingers or hand will be first placed on the treatment area. Pressure will be applied to the soft tissue until the restricted layer was felt, and then the fascia was moved along the surface of the underlying layers while maintaining contact with the deeper layers. Tension will be applied for approximately 60-90 seconds, and if a release will not felt, the duration will extended until the release occurred. MRT will be performed with dry hands, without the use of any intermediary substances, and will be applied in both supine and prone positions. In the treatment program, anterolateral release techniques (targeting fascia superficialis, fascia transversalis, and fascia extraperitonealis) will be applied in the supine position, while posterior release techniques (targeting fascia thoracolumbalis and erector spinae) will be applied in the prone position.

  • OtherKinesio Taping Technique

    Two different techniques will be used in the Kinesio Taping application. First, four I-shaped Kinesio tapes (Kinesio Tex® Gold), each 5 cm wide and 0.5 mm thick, will be applied in a star-shaped pattern using the "space correction technique" with 25-50% tension at the S2-S4 level (sacral region) while the participant will in a seated position. Additionally, to direct the uterus into retroversion during menstruation, a 15 cm long I-shaped tape will be applied to the suprapubic region using the "ligament correction technique" with 100% tension.

06

What researchers measure

Primary outcomes

  1. Pain Severity

    A 100 mm Visual Analog Scale (VAS), represented as a straight line with one end marked as 0 (no pain) and the other end as 10 (unbearable pain), will be used to measure pain severity. Participants will be asked to mark the point on the line that corresponded to the level of pain they will be experiencing during the evaluation. The marked point will be then measured using a ruler, and the numerical value of the pain severity will be recorded. Higher results indicate worse pain intensity.

    Time frame: 3 months

  2. Fatigue

    A 100 mm Visual Analog Scale (VAS), with one end marked as 0 (no fatigue) and the other end as 10 (unbearable fatigue), will be used to evaluate the severity of fatigue experienced on the most intense day of menstruation. Participants will be asked to mark the point on the VAS that corresponded to the level of fatigue they will be felt. The marked point will then measured using a ruler, and the numerical value will be recorded. Higher results indicate worse pain intensity.

    Time frame: 3 months

  3. Menstrual Symptoms

    The "Menstrual Symptom Scale," developed by Chesney and Tatso, will be used to evaluate the severity of menstrual symptoms. This scale consists of 22 items, each with five response options, and includes three subdimensions. The first 13 items belong to the "Negative Effects/Somatic Complaints" subdimension, items 14 to 19 fall under the "Menstrual Pain Symptoms" subdimension, and the last three items are part of the "Coping Methods" subdimension. The responses will be rated on a Likert-type scale ranging from 1 (never) to 5 (always). A higher total score indicates greater severity of menstrual symptoms.

    Time frame: 3 months

07

Study locations

2 sites
  • Cyprus International University
    Mersin, Haspolat 99040, Turkey
  • Cyprus International University
    Mersin, Lefkosa 99040, Turkey
08

References and documents

Publications

  • Ma YX, Ma LX, Liu XL, Ma YX, Lv K, Wang D, Liu JP, Xing JM, Cao HJ, Gao SZ, Zhu J. A comparative study on the immediate effects of electroacupuncture at Sanyinjiao (SP6), Xuanzhong (GB39) and a non-meridian point, on menstrual pain and uterine arterial blood flow, in primary dysmenorrhea patients. Pain Med. 2010 Oct;11(10):1564-75. doi: 10.1111/j.1526-4637.2010.00949.x. Epub 2010 Sep 7. PubMed 21199306 ↗
  • Kaur, A., Ray, G., & Mitra, M. (2017). Comparing the effectiveness of connective tissue mobilisation and kinesio-taping on females with primary dysmenorrhea. Indian Journal of Physiotherapy & Occupational Therapy, 11, 70-5.
  • Harel Z. Dysmenorrhea in adolescents and young adults: etiology and management. J Pediatr Adolesc Gynecol. 2006 Dec;19(6):363-71. doi: 10.1016/j.jpag.2006.09.001. PubMed 17174824 ↗
  • Toprak Celenay S, Kavalci B, Karakus A, Alkan A. Effects of kinesio tape application on pain, anxiety, and menstrual complaints in women with primary dysmenorrhea: A randomized sham-controlled trial. Complement Ther Clin Pract. 2020 May;39:101148. doi: 10.1016/j.ctcp.2020.101148. Epub 2020 Mar 18. PubMed 32379680 ↗
  • Ajimsha MS. Effectiveness of direct vs indirect technique myofascial release in the management of tension-type headache. J Bodyw Mov Ther. 2011 Oct;15(4):431-5. doi: 10.1016/j.jbmt.2011.01.021. Epub 2011 Feb 11. PubMed 21943616 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2022 to primary completion in Nov 2022, 9 months.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 9 months is close to that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 6, 2025
First posted
Apr 13, 2025
StartActual
Feb 6, 2022
Primary completionActual
Nov 14, 2022
CompletionActual
Feb 20, 2025
Last update
Apr 13, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06925087
Lead sponsor
Cyprus International University
Responsible party
Mehmet Miçooğulları (Asst. Prof. Dr., Cyprus International University) — Principal investigator
First posted
Apr 13, 2025
Start date
Feb 6, 2022
Primary completion
Nov 14, 2022
Completion
Feb 20, 2025
Last update
Apr 13, 2025

Study contacts

Mehmet Miçooğulları, PhD
principal investigator · Cyprus International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion